Middle East War Rattles Global Markets as Oil Tops $100 and Dollar Surges 
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership 
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Dollar Strengthens as U.S.-Iran Peace Talks Send Mixed Signals 
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes 
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis 
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion 
U.S. Stocks Tumble as Iran Peace Deal Uncertainty Spooks Markets 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment 
Australia's Inflation Eases in February but Core Pressures Persist 
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint 
Wall Street Slides as Iran War Uncertainty, Oil Surge, and AI Fears Rattle Markets 
Federal Reserve Balance Sheet Reduction: Brookings Research Outlines Possible Path Forward 
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation 
Czech-based Mewery has introduced a prototype of microalgae-based cultivated meat, combining 75 percent pork cells and 25 percent microalgae cells.
The scientific team of Mewery, a cell-based food tech start-up, , cultivated this prototype in 10 weeks.
According to Mewery founder, Roman Lauš, they already have several variants that work for them without animal products and which they continue to work with.
The addition of microalgae improves the product's nutritional value by providing vitamins, antioxidants, minerals, fiber, and vital fatty acids.
Mewery hopes to have the finished product available for sale in two years. Once the necessary legislation is ready, consumers will have access to it.
